Parabilis Medicines sets biotech record with $670m IPO
Parabilis’ US listing means the biotech IPO record has been broken twice in as many months as public listings continue hot streak.
Read the full article on the original site.
Read Full ArticleRead the full article on the original site.
Read Full Article